Insider Transactions in Q1 2025 at Gabelli Healthcare & Wellness Rx Trust (GRX)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 18
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
549
+0.03%
|
$4,941
$9.88 P/Share
|
Mar 11
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100
+0.01%
|
$1,000
$10.09 P/Share
|
Mar 10
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,437
+0.48%
|
$94,370
$10.18 P/Share
|
Mar 07
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,685
+0.14%
|
$26,850
$10.13 P/Share
|
Mar 06
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,210
+0.32%
|
$55,890
$9.97 P/Share
|
Mar 04
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,388
+0.23%
|
$39,492
$9.96 P/Share
|
Feb 28
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,797
+0.25%
|
$43,173
$9.88 P/Share
|
Feb 27
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
955
+0.05%
|
$8,595
$9.89 P/Share
|
Feb 20
2025
|
Mario J Gabelli Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.42%
|
$10,000
$10.2 P/Share
|
Jan 28
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,500
+0.08%
|
$15,000
$10.27 P/Share
|
Jan 22
2025
|
Mario J Gabelli Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+25.0%
|
$9,000
$9.95 P/Share
|
Jan 16
2025
|
Mario J Gabelli Director |
BUY
Open market or private purchase
|
Direct |
4,000
+1.67%
|
$36,000
$9.8 P/Share
|
Jan 10
2025
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,833
+0.76%
|
$133,497
$9.57 P/Share
|
Jan 08
2025
|
Anthonie C Vanekris Director |
SELL
Open market or private sale
|
Direct |
1,115
-9.07%
|
$10,035
$9.65 P/Share
|